National Research Co. (NASDAQ:NRC - Get Free Report) announced a quarterly dividend on Tuesday, May 7th, Zacks reports. Shareholders of record on Friday, June 28th will be paid a dividend of 0.12 per share on Monday, July 15th. This represents a $0.48 annualized dividend and a yield of 1.67%. The ex-dividend date is Friday, June 28th.
National Research has raised its dividend by an average of 31.7% per year over the last three years.
National Research Stock Down 3.4 %
Shares of NRC stock traded down $1.01 during trading on Thursday, reaching $28.75. The company's stock had a trading volume of 68,882 shares, compared to its average volume of 70,429. National Research has a one year low of $28.61 and a one year high of $47.25. The business has a fifty day moving average price of $37.13 and a 200-day moving average price of $39.20. The company has a market cap of $685.80 million, a price-to-earnings ratio of 23.19 and a beta of 0.45. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 0.60.
National Research (NASDAQ:NRC - Get Free Report) last released its earnings results on Tuesday, February 13th. The company reported $0.36 earnings per share (EPS) for the quarter. The business had revenue of $38.00 million for the quarter. National Research had a return on equity of 47.79% and a net margin of 20.84%.
Analyst Ratings Changes
Separately, TheStreet downgraded National Research from a "b-" rating to a "c+" rating in a report on Thursday, January 11th.
Read Our Latest Report on NRC
About National Research
(
Get Free Report)
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.
Featured Stories
Before you consider National Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Research wasn't on the list.
While National Research currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
